Cargando…
Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells
Platinum-based drugs are first-line compounds in the treatment of many solid cancers. Major obstacles are tumors that become resistant and toxic side effects, both largely due to the expression of transporters that mediate the cellular processing of platinum. In this study, we addressed the establis...
Autores principales: | Guttmann, Sarah, Chandhok, Gursimran, Groba, Sara Reinartz, Niemietz, Christoph, Sauer, Vanessa, Gomes, Amanda, Ciarimboli, Giuliano, Karst, Uwe, Zibert, Andree, Schmidt, Hartmut H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787505/ https://www.ncbi.nlm.nih.gov/pubmed/29416650 http://dx.doi.org/10.18632/oncotarget.23142 |
Ejemplares similares
-
Angiotensin II type 1 receptor blockers increase tolerance of cells
to copper and cisplatin
por: Spincemaille, Pieter, et al.
Publicado: (2014) -
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
por: Niemietz, Christoph, et al.
Publicado: (2015) -
Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells
por: Niemietz, Christoph J., et al.
Publicado: (2016) -
The Effect of Zinc and D-Penicillamine in a Stable Human Hepatoma ATP7B Knockout Cell Line
por: Chandhok, Gursimran, et al.
Publicado: (2014) -
Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease
por: Guttmann, Sarah, et al.
Publicado: (2018)